REGENERATE: A PHASE 3, DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED MULTICENTER STUDY OF OBETICHOLIC ACID THERAPY FOR NONALCOHOLIC STEATOHEPATITIS
Vlad Ratziu 1
Arun J Sanyal 2
Leigh MacConell 3
Reshma Shringarpure 3
Tonya Marmon 4
David Shapiro
Zobair Younossi
1 Hôpital Pitié Salpêtrière, Deparment of Hepatology and Gastroenterology, Paris, France
2 Virginia Commonwealth University, Richmond, United States of America
3 Intercept Pharmaceuticals, Inc., San Diego, United States of America
4 Intercept Pharmaceuticals, Inc., San Di
Conference
UEG Week 2016
Citation
United European Gastroenterology Journal; 2016: 2 (Supplement 1)
Login to access library content
Do you need help setting up your myUEG account?
Contact us at [email protected]
New to myUEG?
Social Sharing